Furthermore, the ratio of prolactin levels to tumor volume (PVR) was likewise shown to be predictive for the differentiation of prolactinomas from other types of sellar lesions causing hyperprolactinemia (5). The gene discussed is PRL; the disease is hyperprolactinemia.